V. Opletalo6a´ et al. / Il Farmaco 57 (2002) 135–144
143
their derivatives and analogues), Farm. Obzor LXI (1992) 341–
350.
seems favourable for antimycobacterial activity (Table
5). MIC of the most active derivative 2b was 12.5 mg
ml−1, while rifampicin in the same test was 0.06 mg
ml−1. Compound 2b was also tested against Mycobac-
terium a6ium, a naturally drug-resistant opportunistic
pathogen, and it inhibited the growth of this strain by
32%, MIC\12.5 mg ml−1. Clarithromycin (MIC=4
mg ml−1) was used as the positive control against M.
a6ium. It is important to note that the most active
compound 2b also belongs to the ortho-hydroxyl substi-
tuted series. Further studies are underway aimed at the
detailed elucidation of structure–activity relationships
in the class of chalcones and their analogues to discover
a suitable drug candidate.
&
[11] V. Kozm´ık, P. Lhota´k, Z. Odlerova´, J. Palecˇek, Azachalcone
derivatives and their bis substituted analogs as novel antimy-
cobacterial agents, Collect. Czech. Chem. Commun. 63 (1998)
698–712.
&
[12] V. Kozm´ık, P. Lhota´k, Z. Odlerova´, J. Palecˇek, Azabis-
chalkony—nova´ trˇ´ıda potencia´ln´ıch antituberkulotik (Azabis-
&
chalcones—a novel class of potential antituberculotics), Ces. a
Slov. Farm. 47 (1998) 87–90.
[13] C. Grassi, V. Peona, New drugs for tuberculosis, Eur. Respir. J.
8 (1995) 714s–718s.
[14] W.J. Burman, The value of in 6itro drug activity and pharma-
cokinetics in predicting the effectiveness of antimycobacterial
therapy: a critical review, Am. J. Med. Sci. 313 (1997) 355–363.
[15] V. Opletalova´, A. Patel, M. Boulton, A. Dundrova´, E. Lacinova´,
M. Prˇevorova´, M. Appeltauerova´, M. Coufalova´, 5-Alkyl-2-
pyrazinecarboxamides, 5-alkyl-2-pyrazinecarbonitriles and 5-al-
kyl-2-acetylpyrazines
as
synthetic
intermediates
for
anti-inflammatory agents, Collect. Czech Chem. Commun. 61
(1996) 1093–1101.
Acknowledgements
&
[16] L’. Mitterhauszerova´, K. Kra´l’ova´, F. Sersˇenˇ, V. Blana´rikova´, J.
This study was supported by the Internal Grant
Agency of Charles University (Grant no. 26/1998-BCH
and the Research Project MSM 111600001. Antimy-
cobacterial data were provided by the Tuberculosis
Antimicrobial Acquisition Coordinating Facility
(TAACF) through a research and development contract
with the U.S. National Institute of Allergy and Infec-
tious Diseases.
Cso¨llei, Effects of substituted aryloxyaminopropanols on photo-
synthesis and photosynthesising organisms, Gen. Physiol. Bio-
phys. 10 (1991) 309–319.
[17] W.P. Inskeep, P.R. Bloom, Extinction coefficients of chlorophyll
a and b in N,N-dimethylformamide and 80% acetone, Plant
Physiol. 77 (1985) 483–485.
&
[18] K. Kra´l’ova´, F. Sersˇenˇ, L’. Mitterhauszerova´, F. Dev´ınsky´, E.
Krempaska´, Effect of surfactants on growth, chlorophyll content
and Hill reaction activity, Photosynthetica 26 (1992) 181–187.
[19] J. Bartosˇ, E. Berkova´, I. Setl´ık, A versatile chamber for gas
&
exchange measurements in suspensions of algae and chloroplasts,
Photosynthetica 9 (1975) 395–406.
[20] E. Sido´ova´, K. Kra´l’ova´, L’. Mitterhauszerova´, 3-Alkyl deriva-
tives of 6-acetamido- and 6-nitro-2-benzothiazolinones as plant
growth stimulators, Chem. Papers 46 (1992) 55–58.
[21] T. Irikura, S. Sato, K. Ushiyama, A. Ito, H. Ono, Y. Matsui,
2-Cinnamoylpyrazine derivatives, Japan 71 26 494; Chem. Abstr.
75 (1971) 140885r.
References
[1] J.R. Dimmock, D.W. Elias, M.A. Beazely, N.M. Kandepu,
Bioactivities of chalcones, Curr. Med. Chem. 6 (1999) 1125–
1149.
[22] J. Za´mocka´, D. Dvorˇa´cˇkova´, J. Heger, A. Nagy, D. Mlynarcˇ´ık,
Substituovane´ 2%,5%-diazachalkony a zpu˚sob jejich vy´roby (Sub-
stituted 2%,5%-diazachalcones and the process of their production),
Czech CS 195 582; Chem. Abstr. 97 (1982) 182447j.
[23] D. Dvorˇa´cˇkova´, J. Za´mocka´, J. Heger, A. Nagy, V. Hartelova´,
2%,5%-Diazachalcones I. Preparation, structure and antibacterial
effects of some substituted 2%,5%-diazachalcones, Chem. Zvesti 34
(1980) 263–268.
&
[2] V. Opletalova´, D. Sedivy`, Chalkony a jejich heterocyklicke´ anal-
ogy jako potencia´ln´ı antifunga´ln´ı chemoterapeutika (Chalcones
and their heterocyclic analogues as potential antifungal thera-
peutics), Ces. a Slov. Farm. 48 (1999) 252–255.
[3] V. Opletalova´, Chalkony a jejich heterocyklicke´ analogy jako
potencia´ln´ı terapeutika bakteria´ln´ıch onemocneˇn´ı (Chalcones
and their heterocyclic analogues as potential therapeutic agents
&
&
of bacterial diseases), Ces. a Slov. Farm. 49 (2000) 278–284.
[24] J. Za´mocka´, D. Dvorˇa´cˇkova´, J. Heger, Darstellung and Struk-
turbestimmung einiger Diazachalkone, Z. Chem. 20 (1980) 29–
30.
[4] V. Opletalova´, J. Hartl, K. Pala´t Jr., A. Patel, Conformational
analysis of 2-hydroxy-2%,5%-diazachalcones, J. Pharm. Biomed.
Anal. 23 (2000) 55–59.
[25] J. Za´mocka´, F. Grega´nˇ, Darstellung, Eigenschaften and biologis-
che Aktivita¨t einiger substituiter 2%-,3-,3%-,4- und 4%-Azachalkone,
Pharmazie 48 (1993) 857–858.
[5] J. Sato, Y. Kondo, Y. Kudo, Y. Ito, Preparation of pyrazine
derivatives as herbicides, Jpn. Kokai Tokkyo Koho 06 192 252,
Chem. Abstr. 121 (1994) 280672n.
[26] S.V. Tsukerman, Ya.N. Surov, V.F. Lavrushin, Dipole moments
and infrared spectra of 4- and 4%-monosubstituted chalcones, Zh.
Obshch. Khim. 38 (1968) 524–529, Chem. Abstr. 69 (1968)
6536a.
[27] A.T. Dinkova-Kostova, C. Abeygunawardana, P. Talalay,
Chemoprotective properties of phenylpropenoids, bis(benzyli-
dene)cycloalkanones, and related Michael reaction acceptors:
correlation of potencies as phase 2 enzyme inducers and radical
scavengers, J. Med. Chem. 41 (1998) 5287–5296.
[6] H.-P. Niedermann, R. Eisenacht, Preparation of herbicidal hete-
rocyclic carboxamides, PCT Int. Appl. WO 94 27 974, Chem.
Abstr. 122 (1995) 187621f.
[7] S. Engel, Ch. Nuebling, U. Kardoff, J. Kast, W. von Deyn, P.
Plath, H. Walter, K.-O. Westphalen, M. Gerber, Preparation of
herbicidal pyrazine derivatives, Ger. Offen 4 426 346, Chem.
Abstr. 124 (1996) 317213d.
[8] Handbook of Agriculture, USDA Washington, 1991.
8
[9] R. Kuhn, H.R. Hensel, Uber 2-Azachalkone, Chem. Ber. 86
&
(1953) 1333–1341.
[28] K. Kra´l’ova´, F. Sersˇenˇ, V. Opletalova´, Inhibition of oxygen
&
&
[10] R. Medvecky´, J. Durinda, Z. Odlerova´, F. Pola´sˇek, An-
timykobakteria´lna aktivita azachalkonov, ich derivatov a ana-
logicky´ch la´tok I. (Antimycobacterial activity of azachalcones,
evolution in spinach chloroplasts and Chlorella 6ulgaris by 2%,5%-
diazachalcones, Folia Pharm. Univ. Carol. XXIII (1998) 71–72
Suppl.